[1] [2] Unlike phentermine's central nervous system stimulation, tirzepatide works through multiple mechanisms: it enhances insulin secretion in a glucose-dependent manner, suppresses glucagon release, slows gastric emptying, and reduces appetite through central pathways
Pharmaceutical Sciences: The formulation is studied to optimize multi-peptide stability and gastrointestinal transport
NICE guidance recommends Wegovy as part of specialist weight management services, emphasising a multicomponent approach including behavioural change, dietary advice, and sustainable calorie reduction tailored to individual needs
If approved, the MHRA would assess the benefitrisk profile independently for the UK market, and NICE would subsequently evaluate cost-effectiveness before recommending NHS commissioning
The report authors noted that people may stop treatment before six weeks because of early side effects